← Open Payments lookup

ORNELA IKA: Open Payments

NPI 1477338291 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,253 in 70 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $57 · 2025 $1,253

Food & beverage: $1,253
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$439
E.R. Squibb & Sons, L.L.C.17$235
Lundbeck LLC4$101
Otsuka America Pharmaceutical, Inc.4$78
Alkermes, Inc.3$71
Luye Pharma (USA) Ltd.3$66
Teva Pharmaceuticals USA, Inc.4$63
Vanda Pharmaceuticals Inc.3$56
ABBVIE INC.2$41
Neurocrine BioSciences, Inc.2$33

Products named: CAPLYTA, COBENFY, REXULTI, ABILIFY MAINTENA, ERZOFRI EXTENDED-RELEASE, UZEDY, FANAPT, ARISTADA.

Industry payments across MO — which companies pay providers there.